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ABSTRACT
Introduction: Visceral obesity is associated with an
increased risk of metabolic disorders and occurrence of
chronic diseases. The quantification of the visceral fat
becomes necessary and advantageous in clinical prac-
tice, especially through accurate and precise methods
in replacement of imaging methods as computed to-
mography (CT).
Objective:To present the use of anthropometric in-
dicators that have been linked to visceral fat.
Methods: The selection of items was taken in from
Scopus, Scielo, Lilacs, CAPES journals, PubMed/
MEDLINE and Google Scholar, in the period between
2007 and 2014. Anthropometric and clinical indicators
as waist circumference (WC), waist- to- height ratio
(WHtR), waist-to- thigh ratio (WTR), waist- to- hip ra-
tio (WRH), sagittal abdominal diameter (SAD), abdom-
inal diameter height index (SAD/ Height), abdominal
diameter index (ADI), conicity index (CI), visceral adi-
posity index (VAI) and the lipid accumulation produc-
tion (LAP) were investigated for their relationship with
visceral fat measured by CT.
Results: Most indicators have strong correlation
(r>0.70) with visceral fat. It was observed that there
are few recent studies evaluating this relationship,
especially with the indices derived of the WC and the
SAD, besides the LAP and the VAI. Most studies in-
vestigated the relationship between these indicators
with the diseases that are consequent of the visceral
obesity.
Conclusion: The clinical anthropometric indicators
are accurate in estimating visceral obesity, easy to use
and has low cost enabling clinical nutritional assess-
ment able to intervene earlier and more effectively in
the prevention and/or treatment of this obesity.
KEYS WORDS
Anthropometry, waist circumference, sagittal abdomi-
nal diameter, computed tomography, abdominal obesity.
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RESUMO
Introdução: A obesidade visceral está associada a
um risco maior de distúrbios metabólicos e ocorrência
de doenças crônicas. A quantificação da gordura visce-
ral torna-se necessária e vantajosa na prática clínica,
sobretudo por métodos acurados e precisos em substi-
tuição aos métodos por imagem, como a tomografia
computadorizada (TC).
Objetivo: Descrever a utilização de indicadores clí-
nicos antropométricos que têm sido relacionados à gor-
dura visceral.
Métodos: A seleção dos artigos foi feita no Scopus,
Scielo, Lilacs, periódicos Capes, Pubmed/Medline e
Google Acadêmico, no período entre 2007 e 2014.
Indicadores clínicos antropométricos como circunferên-
cia da cintura (CC), Razão cintura altura (RCA), Razão
cintura coxa (RCCx), Razão Cintura Quadril (RCQ),
Diâmetro abdominal sagital (DAS), Diâmetro abdominal
altura (DAS/ALT), Índice Diâmetro abdominal (IDA), Ín-
dice conicidade (IC), Índice de adiposidade visceral
(IAV) e o Produto de acumulação lipídica (PAL) foram
investigados quanto sua relação com o tecido adiposo
visceral medido pela TC.
Resultados: A maioria dos indicadores tem forte
correlação (r>0.70) com a gordura visceral. Observou-
se que há poucos estudos recentes que avaliaram essa
relação, sobretudo com os índices derivados da CC e do
DAS, além do PAL e o IAV. A maioria dos estudos inves-
tigou a relação entre esses indicadores com as doenças
que são consequentes da obesidade visceral.
Conclusão: Os indicadores clínicos antropométricos
são acurados na estimativa da gordura visceral, fáceis
de utilizar e apresentam baixo custo possibilitando uma
tomada de decisão na avaliação clínica nutricional ca-
paz de intervir mais precoce e efetivamente na preven-
ção de risco de doenças.
PALAVRAS CHAVES
Antropometria, circunferência da cintura, diâmetro
abdominal sagital, tomografia computadorizada, obesi-
dade abdominal.
ABBREVIATIONS
ADI: Abdominal Diameter Index.
AUC- ROC: Area under curve- Receiver Operating
Characteristic.




HDL: High Density Lipoproteins.
LAP: Lipid Accumulation Production.
SAD: Sagittal Abdominal Diameter.
SAD/Height: Sagittal Abdominal Diameter Height
Index.
TG: Triglyceride.
VAI: Visceral Adiposity Index.
VAT: Visceral Adipose Tissue.
WC: Waist Circumference.
WHR: Waist –to-hip Ratio.
WHtR: Waist-to- Height Ratio.
WTR: Waist-to-Thigh Ratio.
INTRODUCTION
Visceral obesity is closely associated with insulin re-
sistance, hypertension, dyslipidemia, type 2 diabetes
and with the high risk of cardiovascular diseases and
mortality1,2. Studies have been reporting that the distri-
bution of the body fat is more important than the
amount of fat itself, since abdominal adiposity, espe-
cially the visceral one, is having a more expressive as-
sociation with the increase of those morbidities3.
It is important to consider that, independently of
overweight, individuals may have visceral obesity rep-
resented by the deposition of visceral adipose tissue.
The more accurate methods for quantifying visceral fat
are the ones using image, such as magnetic resonance
and computed tomography (CT). CT, the comparison
method of this work, is considered to be the “golden-
standard”, able to precisely distinguish visceral fat from
subcutaneous fat in any body region. One of the rea-
sons for that is due to its high reproductability4,5.
However, its high cost, the need of sophisticated equip-
ment, specialized people and the exposition of the indi-
vidual to radiation are the main limitations for its use in
the practice routine and in epidemiological studies5.
This way, anthropometry is considered like an alterna-
tive method for estimating visceral fat, by indicators such
as Waist Circumference (WC) and the Sagittal Abdominal
Diameter (SAD), their respective indexes, Waist-to-
Height Ratio (WHtR), Waist-to-Thigh Ratio (WTR),
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Conicity Index (CI), Sagittal Abdominal Diameter Height
Index (SAD/Height), and the Abdominal Diameter Index
(ADI), which are considered to be low cost, non-invasive
and easy to measure4,6. The Lipid Accumulation Product
(LAP) and the Visceral Adiposity Index (VAI) have been
proposed as alternative parameters for evaluating the
excess of lipids accumulation. Both include anthropomet-
ric and metabolic parameters7-9.
There is no consensus about the anthropometric clin-
ical indicator that better correlates or discriminates vis-
ceral fat, especially when measured by CT, in both
sexes. Then, it becomes fundamental to have a better
comprehension about the detection of visceral fat, be-
cause it is an advantageous and needed replacement in
the evaluation and follow-up in the individual and col-
lective clinical practice. The objective of this revision is
to describe the use of anthropometric clinical indicators
that have been related to visceral fat.
METHODS
For the unsystematic revision, a search was performed
in the databases: Scopus, Scielo, Lilacs, Periódicos from
CAPES, PubMed/MEDLINE and Google Scholar. The fol-
lowing expressions were searched: abdominal fat, vis-
ceral fat, visceral obesity, abdominal obesity, visceral adi-
pose tissue, waist circumference, sagittal abdominal
diameter, Waist-to-Height Ratio, Waist-to-Thigh Ratio,
Waist-Hip Ratio, Conicity Index, Sagittal Abdominal
Diameter Height Index, Abdominal Diameter Index, Lipid
Accumulation Product, Visceral Adiposity Index,
Anthropometry and Computed Tomography. The search
expressions were constructed combining those terms or
using them in an isolated way.
The search criteria for selecting studies were: descrip-
tors present in the title, abstract or subject, documents
in paper format and full available version. Identified
studies have been assessed according to the following
inclusion criteria: (1)- population (adults and elderly),
(2)- theme (visceral fat measured by CT and anthropo-
metrics indicators) and (3)- quantitative approach.
Searches were limited to studies involving humans,
of both sexes, over 18 years old, from any ethnical
group, published in Portuguese, English and Spanish,
and the publishing date was established between 2007
and 2014, besides the incorporation of previously pub-
lished classic works about the theme. The references of
the papers were also analyzed in order to find out stud-
ies that were not identified using the databases.
After selection, articles were read in full and those
that were not within the established criteria were ex-
cluded from the study. For analysis of the studies, data
was summarized in the tables as follows: work identifi-
cation (author and year), location of the study and sam-
ple, and information about the anthropometrics clinical
indicators and the computed tomography and results.
According to the predetermined inclusion criteria, twelve
papers were selected for comparison of studies evaluat-
ing the relationship between anthropometric clinical in-
dicators and visceral fat measured by CT.
RESULTS AND DISCUSSION
Visceral obesity
Currently the interest about the original observation
made by the French doctor Jean Vague 10 about the re-
lation between abdominal obesity and development of
chronic diseases is being renovated. Posteriorly, several
studies pointed to an association between abdominal
adiposity increase with several metabolic disorders and
morbidities, especially cardiovascular diseases, showing
the importance of the localization of fat in detriment of
the total body obesity3.
Therefore, the proof that there is a relation between
the excess of abdominal fat tissue and co-morbidities
such as hypertension, type 2 diabetes, arthritis, coro-
nary artery disease, sleep apnea and some type of can-
cer is not recent. This phenomenon is normally verified
at any level of total body adiposity2,3,11.
It is increasingly notorious the notion that visceral
obesity may be a dysfunctional marker of subcutaneous
adipose tissue leading to the deposition of ectopic fat
(undesirable lipid accumulation in the heart, liver, skele-
tal muscle and pancreas)2.
Abdominal adipose tissue is a complex organ that
may be divided into compartments such as subcuta-
neous and intra abdominal (or visceral) and this last
one into intraperitoneal (or portal) and retroperitoneal,
followed by mesenteric and omental sub-compart-
ments12. However, between those compartments, the
visceral adipose tissue is considered to be the highly
metabolically active risk marker with greater expressiv-
ity for development of the mentioned events.
From the mechanisms through which visceral obesity
may influence the increase of metabolic and cardiovas-
cular risk the highlights are the intense lipolytic activity,
its large adipocytes responsive to lipolytic enzymes and
partially resistant to insulin, determining an inappropriate
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and excessive release of free fatty acids in the portal cir-
culation, finally, triggering a cascade of alterations that
lead to diabetes, hypertension, production of inflamma-
tory cytokines and disorders in the serum lipid profile13.
Age, sex, genetics and ethnicity are huge etiological
factors contributing for the variation in the accumula-
tion of visceral adipose tissue. It has been evidenced
that the commonly used methods to measure body fat
are not able to predict the visceral fat in the same way.
The quantification or estimative of visceral fat is neces-
sary for nutritional clinical evaluation and several meth-
ods and techniques have been developed to evaluate it.
Methods related with the evaluation of visceral
FAT
The more clinically convenient for evaluating visceral
fat are the methods that may be performed quickly,
simply, noninvasive and of low cost, such as the anthro-
pometry. Table 1 presents the main characteristics of
anthropometric clinical indicators which were studied in
this paper.
Table 2 has the resume of studies which observed the
relation between the nutritional clinical indicators and
visceral fat when measured by CT.
Waist circumnference
The measurement of waist circumference is widely
used and has been recommended for estimating the
proportion of abdominal adipose tissue. WC also has
the advantage of being simple and having strong corre-
lation with body mass index and with visceral fat. Its
main limitation consists of the different measuring tech-
niques, which require proper training, especially in very
obese individuals. With regards to the different tech-
Table 1. Resume of the main characteristics of the anthropometric clinical indicators.
Anthropometric clinical indicators Main characteristics
Waist Circumference (WC)
- Evaluates cardiovascular risk and visceral obesity and is one of the criteria for
Metabolic Syndrome.
Waist-to-Height Ratio (WHtR)
- When WC is over half the value of the individual height, it expresses a health risk.
- Has discriminatory power for visceral obesity, cardiovascular risk, high coronary and
mortality risk.
Waist-to-Thigh Ratio (WTR)
- Suggested as a replacement for the waist-height ratio
- Able to estimate visceral fat and its risks.
Waist-to-Hip Ratio (WHR)
- Indicator of fat distribution.
- Care must be taken when interpreting individuals with weight and corporal adiposity
variations.
Conicity Index (CI) - Able to identify fat distribution and the risk of diseases.
Sagittal Abdominal Diameter (SAD)
- Has discriminatory power for visceral obesity.
- Indicator of fat distribution.
Sagittal Abdominal Diameter Height
Index (SAD/Height)
- Correlates with cardiovascular risk and may predict mortality.
- Has discriminatory power for visceral obesity.
Abdominal Diameter Index (ADI)
- Has discriminatory power for visceral obesity.
- Predictor of cardiovascular diseases.
Lipid Accumulation Product (LAP)
- Estimates over-accumulation of lipids.
- Expresses a continuous risk and is a predictor of cardiovascular diseases and mortality.
Visceral Adiposity Index (VAI)
-Expresses the function of visceral fat.
-Has correlation with cardiometabolic risk associated with visceral obesity.
WC: Waist Circumference; SAD: Sagittal Abdominal Diameter; WHR: Waist Hip Ratio; WHtR: Waist-to- Height Ratio; WTR: Waist-to-Thigh
Ratio; SAD/Height: Sagittal Abdominal Diameter Height Index; ADI: Abdominal Diameter Index; CI: Conicity Index; LAP: Lipid accumulation
product; VAI: Visceral adipose index.
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Table 2. Comparison of studies evaluating the relationship between anthropometric clinical indicators and visceral fat measured by com-
puted Tomography.
Studies Anthropometric clinical indicators and visceral fat
Sampaio et al (2007): 92 Brazilians,> 20 years, both
sexes. Excess VAT= 100cm².
VAT measured at L4- L5 and WC at the midpoint
WC: M: r = 0,73 / F: r = 0,77
WHR: M: r = 0,58 / F: r = 0,72
SAD: M: r=0,64; AUC= 0,89 / F: r=0,80; AUC= 0,84
Kanda et al (2007): 419 Japanese diabetic.
VAT measured at L4- L5. Not reported technique for WC.
WC: M: r = 0,78 / F: r = 0,82
Demura & Sato (2007): 112 Japonese, both sexes.
VAT measured at L4-L5. WC: umbilical level.
WC: r=0,66
WHR: r=0,55
Bouza et al, (2008): 108 obese, both sexes.
VAT measured at L4- L5 and WC at the midpoint.
WC: r= 0,62
WHR: r= 0,61
Wu et al (2009): 111 Chinese men (40 - 60 years).




Berker et al (2010): 104 both sexes.
VAT measured at L4- L5 and WC at the midpoint.
WC: M: r = 0,84 / F: r = 0,867
WHR: M: r = 0,739 / F: r = 0,612
Gradmark et al (2010):16 men and 13 Swedish
women.




Yim et al (2010): 5257 Koreans, both sexes.
TAV: measured at the umbilicus.
WC: at the midpoint.
WC: M: r = 0,705 / F: r = 0,636
SAD: M: r = 0,804 / F: r = 0,724
Roriz et al (2011): 197 Brazilians ≥ 20 years, both
sexes. Excess VAT≥ 130cm².
VAT measured at L4- L5. WC at the midpoint.
WC: M: r=0,75 in adults and r=0,77 in elderly/ F: r=0,75 in adults
and r= 0,64 in elderly/ AUC > 0,80
WHR: M: r=0,69 in adults and r= 0,72 in elderly/ F: r=0,69 in adults
and r= 0,49 in elderly
SAD: M: r = 0,70 in adults and r=0,78 in elderly; AUC> 0,79/
F: r = 0,74 in adults and r=0,65 in elderly AUC> 0,84
Barreira et al (2012): 2.037 individuals of a biracial
sample (18-69 years).




WC: Waist Circumference; SAD: Sagittal Abdominal Diameter; WHR: Waist to Hip Ratio; WHtR: Waist-to- Height Ratio; WTR: Waist-to-Thigh
Ratio; SAD/Height: Sagittal Abdominal Diameter Height Index; ADI: Abdominal Diameter Index; CI: Conicity Index; VAI: Visceral adipose in-
dex; LAP: Lipid accumulation product; VAT: Visceral adipose tissue area (cm²) measured by computed tomography. M: men and F: female.
AUC: Area under curve ( ROC curve). All correlactions: p< 0,05.
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niques for measuring it, a systematic review of 120
studies revealed that the place of measurement has no
substantial influence over the association between WC,
cardiovascular diseases, diabetes and mortality risk14.
However, it is a consensus that the most used tech-
nique is the one recommended by the WHO, measured
through the mean point between the last rib and the il-
iac crest15,16.
Currently, this indicator has been receiving important
attention in evaluating cardiovascular risk because it is
a strong predictor of visceral fat with a correlation over
0.70 with VAT, being also one of the criteria to define
the metabolic syndrome17-19.
It may be observed, in Table 2, that Kanda et al.20
and Sampaio et al.18 studies show significant correla-
tion between WC and VAT both for men (r > 0.73) as
well as for women (r > 0.77). Studies with obese pa-
tients21 and in Japanese people22 observed correlation
equal to 0.62 and 0.66 with visceral fat, respectively.
Berker et al.23 observed correlation over 0.84 for men
and women, however when the sample by total body
mass was stratified over or below 30kg/m² the correla-
tions with visceral fat decreased.
In Roriz et al.19 study there was positive correlation in
adults and elderly, being more strong in elderly men
(r=0.77). The cutoff points that identified a VAT area of
risk (≥130cm²) were below the ones recommended by
WHO15 in men (adults = 90.2 cm and elderly = 82.2 cm)
and over them among women (adult = 92.3 cm and eld-
erly = 88.2 cm), concluding that the cutoff points of WC
as a predictor of visceral obesity in elderly are lower
than the ones in adults.
Table 2. continuación. Comparison of studies evaluating the relationship between anthropometric clinical indicators and visceral fat
measured by computed Tomography.
Studies Anthropometric clinical indicators and visceral fat
Roriz et al (2014): 194 Brazilians ≥ 20 years, both
sexes. Excess VAT≥ 130cm².
VAT measured at L4- L5. WC at the midpoint.
WC: M: r =0,76 in adults and r= 0,74 in elderly/ F: r=0,75 in adults
and r= 0,60 in elderly
WHtR: M: r =0,79 in adults and r= 0,79 in elderly/ F: r=0,73 in
adults and r= 0,64 in elderly/ AUC > 0,81
WTR: M: r =0,64 in adults and r= 0,62 in elderly/ M: r=0,53 in adults
and r= 0,35 in elderly
SAD: M: r =0,70 in adults and r= 0,76 in elderly/F: r=0,75 in adults
and r= 0,62 in elderly
SAD/Height: M: r =0,78 in adults and r= 0,79 in elderly/ F: r=0,73
in adults and r= 0,64 in elderly/ AUC > 0,84
ADI: M: r =0,60 in adults and r= 0,66 in elderly/ F: r=0,67 in adults
and r= 0,48 in elderly/ AUC > 0,73
Roriz et al (2014): 191 Brazilians ≥ 20 years, both
sexes. Excess VAT≥ 130cm².
VAT measured at L4- L5. WC at the midpoint.
WHtR: M: r =0,79 in adults and r= 0,80 in elderly/F: r=0,73 in adults
and r= 0,64 in elderly/AUC > 0,81
CI:M: r =0,68 in adults and r= 0,82 in elderly/ F: r=0,72 in adults and
r= 0,47 in elderly
LAP:M: r =0,70 in adults and r= 0,73 in elderly/ F: r=0,61 in adults
and r= 0,60 in elderly/ AUC > 0,78
VAI: M: r =0,50 in adults and r= 0,56 in elderly/ F: r=0,38 in adults
and r= 0,47 in elderly/ AUC > 0,65
WC: Waist Circumference; SAD: Sagittal Abdominal Diameter; WHR: Waist to Hip Ratio; WHtR: Waist-to- Height Ratio; WTR: Waist-to-Thigh
Ratio; SAD/Height: Sagittal Abdominal Diameter Height Index; ADI: Abdominal Diameter Index; CI: Conicity Index; VAI: Visceral adipose in-
dex; LAP: Lipid accumulation product; VAT: Visceral adipose tissue area (cm²) measured by computed tomography. M: men and F: female.
AUC: Area under curve ( ROC curve). All correlactions: p< 0,05.
However using only the waist circumference may
have an important limitation. For a given measurement
of waist circumference, some individuals will have an
increased amount of visceral fat, while in others the
larger content may be subcutaneous, thus, not distin-
guishing visceral fat from the subcutaneous one24.
Among women in advanced age, for the same WC,
there is a larger amount of visceral fat than among
younger women6.
Waist– to- height ratio
The value of WC will depend on the individual height
in order to express a health risk. Thus, its interpretation
must be judicious, especially when individually and iso-
latedly evaluated. Thus, by taking height into consider-
ation, the Waist-to-Height Ratio seems to be better
than WC for discriminating cardiometabolic risk, espe-
cially in individuals of short stature25.
WHtR is determined by the ratio between WC (cm)
and Height (cm), and is considered a simple, fast, low
cost trial tool superior than BMI for evaluating health
risks and mortality by cardiovascular disease (CVD) and
for all the causes26-28.
Despite the limitation represented by the absence of
a specific cutoff point, the average value of 0.50 was
suggested, allowing its use in both sexes, different
age groups and ethnicities for predicting cardiometa-
bolic risk29-31. This value has been used to support the
simple message of public health “keep your waist cir-
cumference between the half of your height”.
However, a meta-analysis found that in non-Asian
populations the ideal cutoff was higher than in Asian
ones25. The different measurement techniques of WC
and the height averages between the population
would justify this variation.
Several studies showed discriminatory power of
WHtR for different morbidities, mainly high cardiovas-
cular and coronary risk as well as for mortality6,30,32-34.
However, few studies evaluated the relation between
WHtR and the VAT area measured by CT. Barreira et
al.17 in an study with 2037 individuals between 18 and
29 years old from a biracial sample verified correlations
over 0.59 and Gradmark et al.35 observed high correla-
tions (r> 0.81) of WHtR and WC with the area of vis-
ceral fat measured by CT in Swedish adults. Wu et al.36
showed that WHR was a stronger predictor of visceral
fat than WC, BMI or WHtR in Chinese men. Studies in
Brazil37,38 observed strong correlation of WHtR with vis-
ceral fat, in adults and elderly of both sexes and
showed that when WC was divided by height it had a
better discriminatory power for detecting visceral obe-
sity with cutoffs of 0.54 and 0.55 in men and of 0.59
and 0.58 in adult women and in elderly, respectively.
Among the mechanisms which explain the health
risk previewed by WHtR it is suggested that the risk
may be explained due to its strong association with el-
evations of abdominal obesity which trigger the men-
tioned morbidities.
Waist-to-thigh ratio
The Waist-to-Thigh Ratio is found by dividing the
waist circumference by the thigh circumference. It was
suggested as a substitute of the Waist-to-Hip Ratio and
able to estimate visceral fat and its respective risks39.
WTR does not considers the proportionality regarding
the stature, it may remain unchanged if there is a pro-
portional increase or decrease in the measurement of
its circumferences.
There are few studies comparing this index with WC
alone. Most of the studies with WTR investigated its re-
lationship with diseases in consequence of obesity and
not with visceral fat as this work pretended. Roriz et
al.37 observed strong correlation of WTR with the vis-
ceral fat area, except in elderly women and good accu-
racy in discriminating the excess of this adiposity. Most
of the studies related this indicator with other outcom-
ings40-42. In a sample representing 11.437 american
adults it was observed that WTR had the stronger as-
sociation with mortality and that the increase in mortal-
ity risk of men was not specially related with increased
WC, but with a relative decrease of the thigh circumfer-
ence43. Reis et al.44 showed that WTR and WHR in-
crease the prediction of mortality in individuals with
normal weight and in obese ones.
Waist-to-hip ratio
The Waist-to Hip Ratio is determined by the division
between waist circumference and hip circumference. It
is an indicator used to identify the type of body fat dis-
tribution. Values above 1.00 for men and 0.85 for
women indicate a distribution of the android type, cen-
tral or abdominal, considered as risky for development
of cardiovascular diseases due to the great concentra-
tion of fat in this region. Values above those cutoffs in-
dicate a distribution of the gynaecoid type, peripheral
or gluteal-femoral of smaller cardiovascular risk45.
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One of the main limitations for its practical use is its
incapacity of detecting changes during the follow-up of
individuals in treatment for weight loss, since the WC
measurement varies simultaneously with the hip meas-
urement, keeping WHR constant. Also, hip measure-
ment does not considers variations in the pelvic struc-
ture between individuals, nor the reduction of tissues in
this area with the aging process. There is, still, incapac-
ity of WHR in differentiating accumulation of subcuta-
neous visceral fat46. Independently of body adiposity
the individuals may have equal values of WHR, even
with substantial inter-individual variation in the total
body fat and in the areas of visceral and subcutaneous
and visceral abdominal adipose tissue47.
Several studies evaluated the correlation between
WHR and visceral fat observing that in comparison with
other anthropometric indicators, WHR had smaller cor-
relation with this tissue17-19,21-23,35,36. The use of this in-
dicator as a predictor of visceral fat must be cautious,
mainly in individuals with variations of weight and body
adiposity.
Conicity index
Conicity index has the objective of identifying the
distribution of fat and the risk of diseases. This index
is based on the idea that the human body changes
from a cylindrical shape to a “double cone” with the
accumulation of fat around the waist and its theoreti-
cal range varies from 1.00 to 1.73. The CI is calculated
by the following equation48: WC/0.109 √(BW/H)
where: WC = waist circumference (m); BW = body
weight (kg); H = height (m).
One limitation for using CI in epidemiological studies
is the lack of consensus about cutoffs for identifying
cardiovascular risk, besides the difficulty of calculation
proposed by its formula. Pitanga & Lessa49 proposed a
table with values for the denominator of the CI equa-
tion for the ease of use.
This index increases according to the accumulation of
abdominal fat increasing the risk of diseases47. Studies
show that CI has been a good predictor of High
Coronary Risk with the Area Under the ROC Curve of
0.80 (95% CI: 0.74-0.85) in men, of cardiovascular risk
and hypertension in adults49-51. A study with 191
Brazilians38 observed strong correlation and accuracy of
CI with the area of visceral adipose tissue measured by
CT, especially in adults (r= 0.68) and elderly (r=0.82)
men and in adults women ( r= 0.72).
Despite existing a relationship between CI and the
mentioned morbidities there is a lack of studies using
the index as a predictor of visceral obesity.
Sagittal abdominal diameter
Sagittal Abdominal Diameter may be measured an-
thropometrically or by image methods, such as CT. SAD
has been appointed as an important anthropometric in-
dicator for estimating visceral adipose tissue18,19,52,53.
The measurement in supine position better estimates
the fat tissues more associated with CVD risk, being this
the more widely used technique by researchers. This
technique is based in the principle that with individuals
in this position the increase of visceral fat accumulation
keeps the abdomen height in the sagittal position while
subcutaneous abdominal fat reduces abdominal height
due to the force of gravity54.
From SAD other anthropometric indexes are derived,
the ratio between SAD and height (SAD/Height) and
the ratio between SAD and WTR or the Abdominal
Diameter Index (ADI). SAD/Height has similar or supe-
rior correlation with cardiovascular risk when compared
with WHR and may predict mortality as well as SAD47,55.
ADI is considered as an effective indicator for estimat-
ing visceral adipose tissue, a better predictor of coro-
nary disease than WTR and of risk for cumulative inci-
dence of ischemic CVD56,57.
However SAD has been studied more as an isolated
measure of fat distribution than its indexes and, when
related with the other anthropometric indicators or clin-
ical parameters, shows to be superior as a measurement
of visceral obesity and coronary disease index. Stevens
et al.58 suggested WC and SAD instead of BMI for eval-
uating the cardiovascular risk profile among individuals
in different populations and ethnicities. Other studies
show SAD as a marker of risk factors for CVD53,59-61.
Sampaio et al.18 carried the first study of SAD valida-
tion in Brazil and observed high reliability (inter-class
coefficient = 0.99) and high correlation of this measure
and abdominal visceral fat area measured by CT
(r=0.80 for women and r=0.64 for men). Cutoffs of
19.3 cm and 20.5 were identified for men and women,
respectively, with better sensibility and specificity corre-
sponding to the area of visceral fat excess (> 100cm²).
Another Brazilian study19 with a larger sample observed
correlations over 0.7 between SAD and visceral fat area
and posteriorly SAD indexes were evaluated, with high
correlation being observed between SAD/Height and
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ADI and this fat, especially in men, with greater accu-
racy for SAD/Height (AUC-ROC > 0.84) showing better
influence of height in SAD measurement for discrimi-
nating visceral obesity ( VAT area ≥ 130m²)37.
Yim et al.62 observed greater correlation of SAD with
visceral fat than WC in 5,257 adult Koreans, in both
sexes. Kullberg et al.63 showed correlations over 0.78,
however, visceral fat was measured by magnetic reso-
nance and not CT, the focus of this study.
Although SAD and its indexes are simple and low cost
methods, it is unlikely that they will replace the indica-
tors that contemplate circumferences, measured by in-
elastic tape, of large applicability in clinical practice.
Vasques et al.64 in their revision study with some of
those indicators verified that, generally, WC and SAD
correlated more with visceral fat than BMI and WHR.
Lipidic accumulation product
Lipidic Accumulation Product is a simple indicator de-
veloped to express a continuous risk and predictor of car-
diovascular diseases and mortality and is obtained by for-
mulas proposed by Kahn9. For the masculine sex, LAP =
(CC[cm] – 65) × (triglycerides [mmol/L]) and feminine,
LAP= (CC[cm] –58) × (triglycerides [mmol/L]). It esti-
mates the over-accumulation of lipids and suggests that
the values of WC and serum triglyceride (TG) are prone
to accumulate along time, in other words, they express a
function of constant risk associated with the cardiovascu-
lar risk among adults9.
Kahn9 stated that LAP rises faster according to the
age for men than for women, which may contribute for
the increase of cardiovascular events in younger men.
Studies presented more discriminatory capacity of LAP
for the incidence of diabetes similarly to BMI, WHR and
WHtR and for identifying Metabolic Syndrome in men
and women65,66.
Recently, Roriz et al.38, was the first one evaluating
the performance of LAP for discriminating visceral fat
and observed correlations over 0.7 in men and over
0.60 in women, with area under the ROC curve over
0.78 and cutoffs ranging from 26.4 to 37.4 in men and
from 40.6 to 44.0 in women, showing the good accu-
racy of this indicator.
Visceral adiposity index
The Visceral Adiposity Index also expresses the func-
tion of visceral fat and its peculiarity consists in reflect-
ing the altered production of adipocytokines, increase
of lipolysis, plasma and free fatty acids – factors that
are not identified by BMI, WC, TG and high density
lipoproteins (HDL) separately8. In consequence, it is an
index proposed as a substitute marker of dysfunction
and distribution of adipose tissue and independently
correlated with cardiometabolic risk associated with vis-
ceral obesity. The visceral adiposity index (VAI) is ob-
tained by formulas proposed by Amato et al.8: for fe-
males VAI = (WC/36.58+(1.89 x BMI)) x (TG/0.81)
x (1.52/HDL) and for males, VAI= (WC/39.68+(1.88
x BMI)) x (TG/1.03) x (1.31/HDL).
Knowles et al.67 showed that VAI, WC and WHtR are
correlated with cardiovascular risk as predictors of
Metabolic Syndrome. Bozorgmanesh et al.68 and Elisha
et al.69 showed that VAI was not superior than anthro-
pometric indicators, being a weak indicator for forecast-
ing cardiovascular diseases and for visceral adipose tis-
sue function. Roriz et al.38 observed positive correlation,
especially in adult and elderly men, as showed in Table
2. A study70 observed high correlation of serum levels of
triglycerides and HDL, mainly in elderly, which com-
pound VAI formulas and concluded that the average of
the visceral adipose tissue area was always more ele-
vated when triglycerides values were altered, both in
adults and elderly.
The VAI is proposed as being able to evaluate the
dysfunction of the adipose tissue and its association
with cardiometabolic risk, mainly in the absence of a
manifested metabolic syndrome7.
Both LAP and VAI are still few explored about their
capacity of discriminating visceral fat excess, especially
measured by CT. However, those indicators have large
possibilities for future investigations.
METHODOLOGICAL LIMITATIONS
Most of the studies used different methodologies re-
garding anthropometric techniques and the image
method for quantifying visceral fat, besides different
cutoffs of the TAV area. The lack of standardization be-
tween the adopted protocols indicates a limiting factor
when comparing data from the different studies.
CONCLUSION
Considering the importance of visceral fat as a deter-
minant of metabolic changes associated with obesity,
the replacement of CT by simpler methods of low cost
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and free of radiation means an advancement in the di-
agnosis of visceral obesity and in the prevention of
events associated with this adiposity.
Most of the studies evaluated the relationship be-
tween anthropometric clinical indicators with diseases
resulting from visceral obesity, however, this work con-
cluded that there are few recent studies evaluating the
relationship between those indicators and visceral fat
measured by CT, especially with the ones derived from
WC and SAD, LAP and VAI.
In face of the presented studies, the most consistent
results were from WC, WHtR, CI and SAD because they
have better correlation and accuracy for estimating vis-
ceral fat when compared with the other indicators. The
remaining indicators have been demonstrating positive
results, however, WC and WHtR have the advantage of
being more practical, fast, simple and not demanding
formulas.
Generally, the anthropometric clinical indicators are
accurate for estimating visceral fat. However, caution
must be taken when interpreting those indicators, es-
pecially when evaluated individually and isolatedly. The
investigation about alternative methods which estimate
visceral obesity is essential for the decision taking dur-
ing the nutritional clinical evaluation able to intervene
earlier and more effectively in the prevention of dis-
eases risk.
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